R&D Systems Recombinant Human Osteocrin Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9669ON050
Measured by its binding ability in a functional ELISA. When Recombinant Human NPRC/NPR3 Fc Chimera (Catalog # 10233-NR ) is immobilized at 2µg/mL (100µL/well), the concentration of Recombinant Human Osteocrin that produces 50% of the optimal binding response is 2-20 ng/mL.The Recombinant Human Osteocrin Protein is derived from E. coli. The Recombinant Human Osteocrin Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|<0.10 EU per 1μg of the protein by the LAL method.|
|MUSCLIN, osteocrin, OSTN|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Reconstitute at 250μg/mL in PBS.|